Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 25Lymphoma 15Neutropenia 9Lymphoma, Large B-Cell, Diffuse 7Leukemia 7Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Triple Negative Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Hodgkin Disease 4Chemotherapy-induced Neutropenia 4Urinary Bladder Neoplasms 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Colorectal Neoplasms 3Burkitt Lymphoma 3Breast Neoplasms, Male 3Adenocarcinoma, Bronchiolo-Alveolar 3Adenocarcinoma of Lung 3Waldenstrom Macroglobulinemia 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma 2

Interventions

Cyclophosphamide 13Doxorubicin 9Trastuzumab 8Taxes 7Paclitaxel 7Docetaxel 5Carboplatin 5Albumin-Bound Paclitaxel 5Radiotherapy 4Epirubicin 4pertuzumab 3pembrolizumab 3Melphalan 3130-nm albumin-bound paclitaxel 3eribulin 2Thiotepa 2Tamoxifen 2Peripheral Blood Stem Cell Transplantation 2Lapatinib 2Fluorouracil 2Filgrastim 2Bevacizumab 22C4 antibody 2trastuzumab biosimilar HLX02 1talimogene laherparepvec 1sargramostim 1ruxolitinib 1romidepsin 1pegfilgrastim 1pazopanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Inflammatory Breast Neoplasms × pegfilgrastim × Clear all
NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

SWOG Cancer Research Network

Phase 2 Completed
215 enrolled 13 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡